Evosep develops technologies and solutions for protein-based clinical diagnostics, focusing on making sample separation faster and more robust than existing alternatives.

Evosep

Evosep One

Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster.

We are targeting the growing need for throughput with robust solutions for clinical and large-scale proteomics, and we have a very ambitious business plan to bring the community closer to the clinic.
 
We are basing our design on years of experience with nano-UHPLC R&D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis.

Vaekstfonden

Novo Holdings

Evosep Biosystems

Next stop: The Evosep HQ in #Odense
 
Join Camilla, Joel, Magnus, and Maurine from Evosep as we take part in the Bruker eXceed Nordic Seminars Tour.
 
On September 5th we are happy to host the Bruker Daltonics eXceed event at our HQ and share insights on the latest breakthroughs in #proteomics and #lifescience research.
 
This is a great opportunity to connect, learn, and drive #innovation together as we push boundaries in proteomics.
 
Don't miss out. Secure your seat here: https://lnkd.in/eNYFm_UR

What a night! 

Together with, friends, colleagues and collaborators we celebrated the grand opening of our new facility. It was a fantastic evening filled with great company and a shared excitement for the future so thank you to everyone who joined us to toast to new beginnings. 

This move marks a significant milestone for us and we’re thrilled to be expanding our production and laboratory capacities in this state-of-the-art facility. With lots and lots of space and close proximity to key institutions like the Syddansk Universitet - University of Southern Denmark and the new University Hospital, we are excited to continue our commitment to making proteomics more accessible and efficient for all. 

A special thanks to Peter Rahbæk Juel, the Mayor of Odense, for adding a touch of ceremony—and a bit of fun—to our event. He teamed up with Morten Bern and Ole Vorm, to cut the official ribbon! 

#biotech #lifescience #madeinodense #proteomics

Viral infections are usually diagnosed with PCR or immunoassays. This study introduces vPro-MS, a proteomics workflow for untargeted virus identification from patient samples. Using a peptide library covering 331 viruses, vPro-MS enables high-throughput analysis with >99.9% specificity. It offers sensitivity comparable to metagenomics, allowing large-scale virus detection in biofluids like human plasma. #proteomics #patientsample #bloodplasma

Read the study here: https://lnkd.in/d-rCBfSU

Evosep is at #IMSC2024! 
Join us at booth 04 to discover how our innovative proteomics solutions can revolutionize your research. Also, don't miss our lunch seminar! We still have seats available for our lunch seminar with Prof. Jesper Velgaard Olsen and Prof Birgit Schilling on Wednesday. 
Registration details in the comments below.
#proteomics #research #massspectrometry #melbourne

Say hello to Tina Ebbesen, the newest member of our team.
 
Tina holds a master’s degree in Intercultural Marketing from Copenhagen Business School and specializes in social events and branding. At Evosep, she will be managing our presence at industry conferences and strengthening our promotional campaigns.
 
Please join us in giving Tina a warm welcome to Evosep!
#proteomics #evosep #team #lcms

Building a strong team goes beyond the office walls. Taking time to connect with colleagues outside of work not only strengthens team spirit but also fosters a healthier, more vibrant work environment. 

Yesterday, we put this into practice when the team ran the annual DHL relay race in Odense. It was a great evening of running together, challenging ourselves, and building team spirit. #proteomics #team #lcms

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 1, 2024 10:28 AM	a07cb85b
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 4, 2024 10:53 AM	b5e03896
crunchbase profile	general
li profile	general	Sep 1, 2024 10:28 AM	14646ce2
translate crunchbase fundingrounds	general
peers	general	Sep 1, 2024 10:28 AM	c86d1ef5
news basic	general	Sep 1, 2024 10:28 AM	a4a57dc9
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

EVOS

COM:EVOSEP

Evosep